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Proteins are highly dynamic entities. Their myriad functions require specific structures, but
proteins’ dynamic nature ranges all the way from the local mobility of their amino acid con-
stituents to mobility within and well beyond single cells. A truly comprehensive view of the
dynamic structural proteome includes: (i) alternative sequences, (ii) alternative conformations,
(iii) alternative interactions with a range of biomolecules, (iv) cellular localizations, (v) alterna-
tive behaviors in different cell types. While these aspects have traditionally been explored one
protein at a time, we highlight recently emerging global approaches that accelerate comprehen-
sive insights into these facets of the dynamic nature of protein structure. Computational tools
that integrate and expand on multiple orthogonal data types promise to enable the transition
from a disjointed list of static snapshots to a structurally explicit understanding of the dynamics
of cellular mechanisms.
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1 Introduction
The human genome sequence has a smaller number of genes
than expected:19 000 compared to 6.7 million genes in ear-
lier estimates [1]. It has remained largely unclear how this
small number of genes can be sufficient to support human
complexity. In recent years, hierarchical layers of regulation
have been revealed that give rise to some of the functional
complexity observed in living cells despite the compact na-
ture of the protein coding genome. These are directly linked
to spatiotemporal dynamics on all levels of protein structure
from their sequence, three-dimensional structure to alterna-
tive cellular localizations and spatial organization of specific
proteins in tissues and organs. We discuss these new regu-
latory mechanisms which contribute to emergent complexity
of living systems (Fig. 1), as follows:
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(i) About 80% of the human genome maps to non-coding
yet functional genomic elements [2]. These regulatory
elements include sites for DNA methylation, DNase I
hypersensitive regions that function as preferential in-
teraction sites for transcription factors and long-range
regulatory elements. Fine-tuning the control of tran-
scription makes it possible to switch among a large
variety of transcriptional states depending on intracel-
lular and extracellular changes.
(ii) Alternative splicing has been implicated in tissue dif-
ferentiation and is positively correlated with organism
complexity [3–5]. Alternative splicing is an important
mechanism to generate multiple sequence variants
from the same gene, for instance in different tissues
or developmental stages [6].
(iii) Post-translational modifications (PTMs) such as phos-
phorylation [7] and acetylation [8] crucially modulate
protein function. PTMs further expand the space of
alternative sequence variants of proteins.
(iv) Intrinsically disordered proteins (IDPs) and intrinsi-
cally disordered regions (IDRs) can assume alternative
secondary and tertiary conformations. This expands the
available space of alternative structures [9].
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(v) Switchable alternative protein–protein interactions lead
to yet more diversity [10]. IDPs can engage in a large
number of alternative interactions as function of PTM
and overlapping short linear motifs. Some IDPs use
overlapping linear segments for binding to multiple,
distinct protein partners with low affinities [11], thus
enabling rapid rewiring of large cellular interaction net-
works; these same capabilities enable the rapid rewiring
of gene regulatory networks [6, 12, 13].
(vi) Protein turnover. The half-lives of eukaryotic proteins
range from on the order of minutes to decades [14,15].
Such differential protein turnover leads to a greater
range of protein abundance than for example, transcript
abundance. Transcripts vary some 2 orders of magni-
tude in their cellular abundance whereas proteins cover
a dynamic range greater than 6 orders of magnitude or
higher in some cell types. Low-abundant proteins are
turned over more rapidly by proteasomal proteolysis,
contain more IDRs and are enriched in PEST motifs
[16, 17].
(vii) Multiple subcellular locations enable the same protein
to exert different functions in different parts of the cell
[18].
(viii) Proteins involved in transducing intrinsic and extrinsic
signaling exist within spatially restricted concentration
gradients. For example, Wnt signaling gradients con-
trol asymmetric cell divisions during early development
and later in the life of complex organisms maintain tis-
sue organization. Spatial organization enables the for-
mation of complex tissues and organs up to the highly
interconnected human brain.
The term “proteoform” has been recently proposed as an
umbrella term to summarize all possible alternative protein
sequences for a givenprotein including genetic sequence vari-
ants, PTMs, splice variants, proteolysis variants [19]. Powerful
methods to characterize proteoforms have been comprehen-
sively covered in several excellent papers [20–22]. It should
be added at this point that IDPs and IDRs can be viewed
as “outliers” in the context of structural biology terminology:
Folded proteins are readily described by the well-established
hierarchy of 1D structure (i.e. protein sequence) to 2D struc-
ture (i.e. local secondary structure elements) to 3D structure
(i.e. atomic coordinates of atoms of a folded protein chain),
but IDPs lack a fixed 2D or 3D structure and therefore elude
a straightforward classification in the established terminol-
Figure 1. Challenging questions in proteomics. The proteome is
not a fixed entity but a dynamic system. Unraveling a multitude
of dynamic layers of its regulation is key to comprehensive un-
derstanding.
ogy framework. To cope with this phenomenon, it was re-
cently suggested to extend the concept of “proteoforms” to
includemanifold alternative conformations of IDPs and IDRs
as “conformational (or basic or intrinsic) proteoforms” [23].
Other authors have used various descriptors for IDPs, [24]
including “4D proteins” [25] to indicate that their conforma-
tions and functions can change over time or, alternatively,
other authors have attempted to classify IDPs by physical
parameters such as charge patterns, IDR length and resid-
ual structure [26]. While an in-depth discussion of the is-
sue of IDP classification and terminology is clearly beyond
the scope of this viewpoint, it is important to acknowledge the
current imperfections of our terminology and to encourage
community-wide efforts to find a new consensus solution for
a more effective terminology that would fully integrate IDPs
and IDRs into the terminology of biological sciences.
Compared to extensive insights into multiple aspects
of proteoforms, much less is known about higher-order
structural proteome dynamics that enable cellular complexity
(Fig. 1). We focus on recently developed methodologies de-
signed to study dynamic protein conformations, interactions,
and subcellular mobility. We also present a brief summary of
what we consider to be remaining key challenges in studying
the structure and function of cellular proteomes.
2 How can alternative structures tune
functional protein interactions (and
vice versa)?
Not all protein interactions fit the classical lock and keymodel
of molecular recognition achieved by docking of rigid compo-
nents. Fine-tuning target recognition can require ‘conforma-
bility’ as in the case of bacterial Lac repressor protein, which
assumes a fuzzy complex when sliding along non-specific
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DNA sequence but a mostly structured state in the specific,
tightly DNA-bound complex once associated with its specific
target sequence [27]. Similar observations have beenmade for
human sequence-specific transcription factor LEF1 which is
mostly disordered free in solution but assumes a defined 3D
structure in complex with its specific target DNA [28]. Even
more pronounced structural transitions fromunstructured to
pathologically structured fibril conformations can contribute
to neurodegenerative disorders as in the case of Parkin-
son disease, which is associated with toxic accumulation of
-Synuclein aggregates [29]. Many cell-regulatory hub pro-
teins contain IDRs [30]. Adenomatosis polyposis coli (APC),
a tumor suppressor protein, is frequently mutated in cancer,
and cancer mutated forms of APC often lack most of their
2000 residue long IDR. Axin1, an interaction partner of APC,
can gain pathological functions if single point mutations dis-
rupt the normal fold of a small folded domain that is located
between its long IDRs [31–33]. Increasing largely anecdotal
evidence suggests that both transient and persistent struc-
tural disorder play crucial roles in biology and understanding
disease mechanisms and that there is no unique disordered
state but rather a continuum from fully structured to fully
disordered [34, 35].
3 “LEGO brick” structural biology is
getting more dynamic
3.1 X-ray crystallography beyond static structures
Traditionally, structural biology was rationalized by the
dogma that biological function requires a rigid 3D protein
structure. According to this dogma, it should be possible to
understand biology by solving one minimal energy struc-
ture per protein. Greater than 100 000 structures of folded
domains have been solved over the last decades and first
near-complete structural proteome models have been pro-
posed based on homology modeling [36]. 90% of these pro-
tein structures have been solved using X-ray crystallography,
which is intrinsically restricted to the solid phase of proteins.
Structural protein dynamics in solution are, therefore, incom-
pletely characterized so far.
Despite its historical bias towards solving static structures,
X-ray crystallographyhas chiefly contributed to the birth of the
IDP field [37] as thousands of polypeptide segments in crys-
tallised protein constructs do not give rise to a well-defined
electron density and can therefore be classified as “disor-
dered” [38]. More direct time-resolved methods are currently
under development building on the latest advances in high-
brilliance X-ray sources. Spectacular first dynamic pictures of
ultrafast light-induced femtosecond isomerization events in
the photoactive yellow protein and alternative conformations
of riboswitches dynamically reshaping upon ligand-binding
highlight the possibility of capturing dynamic structural data
in the future [39, 40]. In addition to exciting technological
developments, it will be interesting to explore improved com-
putational possibilities for a more comprehensive analysis
of existing X-ray crystallographic datasets: further improve-
ments are possible by treating protein dynamics explicitly and
enabling improved fitting of existing electron densitymaps to
alternative conformations and locally flexible parts in proteins
[41].
Even fully disordered proteins are no longer outside of the
reach of X-ray crystallography. Several important c-Myc struc-
tures have been solved in complex with specifically binding
partner proteins [42]. It is hoped that this will make previ-
ously undruggable IDPs specifically targetable by exploiting
unique interfaces that only arise in specific protein–protein
complexes of these IDPs [43]. X-rays can make numerous
protein dynamics crystal clear.
3.2 Cryo-EM and NMR – a dynamic pair
In the last two decades, major technological breakthroughs
in electron detection efficiency and image processing have
culminated in a recent explosion of new Cryo-EM structures,
which is experiencing a higher average annual growth com-
pared to x-ray crystallography (with an average of 34 versus
9%). Cryo-EM, like NMR spectroscopy, is capable of revealing
local structural disorder. NMR peaks of disordered protein
segments cluster together more closely because their more
averaged chemical environments result in lower chemical
shift dispersion [44]. Anisotropic Cryo-EM resolution scales
with flexibility [45], i.e. highest resolution is achievable for
rigid and lowest resolution for very flexible regions [46]. Their
preferredmolecular size ranges are complementary: typically
below 50 kDa for NMR and above 150 kDa for Cryo-EM.
While the rate of progress is nicely accelerating, costs of state
of the art Cryo-EM and NMR facilities still restrict broader
community access to these technologies. Establishing op-
timal protein production protocols and sample conditions
remain shared bottle-necks among all high-resolution struc-
tural techniques [47, 48]. While the contribution of NMR to
solving new structures might shrink in the future, it cannot
be over-emphasised that this technique has unique capabil-
ities in covering directly a large range of protein solution
dynamics on timescales ranging from picoseconds to hours
[49]. Briefly, all major high-resolution structural biology tech-
nologies continue to develop dynamically and complement
each other.
3.3 Biochemical approaches to study protein
conformational dynamics
Many aspects of protein conformational dynamics are ei-
ther impractical or impossible to study using exclusively
above-mentioned high-resolution structural methods. Bio-
chemical methods including 1D SDS-PAGE and proteoly-
sis have been successfully used as valuable complementary
methods to characterize protein folding and conformational
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heterogeneity in solution [50]. Short digestion protocols as in
pulse proteolysis [51, 52], membrane pulse proteolysis [53],
SILAC pulse proteolysis [54], and FASTpp [55] considerably
increased throughput in recent years. FASTpp uses thermal
denaturation in contrast to chemical denaturation in pulse
proteolysis. FASTpp exploits the principle of rapid diges-
tion of exposed, thermally unfolded polypeptide segments
before they had a chance to aggregate. FASTpp detects ligand-
induced folding and stabilisation, missense mutation effects
on protein stability [56–58]. While FASTpp is technically sim-
ple and fast to implement without the need to equilibrate
samples in denaturant, which can take months in the case of
kinetically stable proteins [59], pulse proteolysis can be used
to derive equilibrium unfolding energies (Gs).
Limited proteolysis (LiP) has been used for many decades
in structural biology and continues to be actively developed
using a wide range of proteases and readout methods from
low to high multiplexity [60,61]. A recent breakthrough study
used LiP in combination with peptide sequencing by mass
spectrometry to simultaneously map conformations of 1000
yeast proteins and to reveal quantitative structural changes in
300 proteins upon growth on different sugars [62,63]. Similar
methods combining the best of classical biochemical meth-
ods and ultra-sensitive and large-scale protein detection have
a great potential for revealing structural proteome dynamics
under a large range of biological [64], physical, and chemical
conditions, thereby redefining our understanding of protein
stability and folding in the cellular context.
3.4 Label-dependent protein folding assays
A wide range of highly specific methods to study protein con-
formations depends on selective chemical protein labeling.
Tryptophan-free proteins can be selectively labeled using a
single tryptophan substitution of a chemically similar aro-
matic residue like phenylalanine, which often does not per-
turb the biological behavior of the wild-type protein [65, 66].
Another more widely used chemical labeling method is hy-
drogen deuterium exchange (HDX). As all proteins contain
hydrogens, their exchange with deuterons presents a very
generic and minimally perturbing strategy of labeling. Hy-
drogens are ubiquitous in proteins yet local hydrogen to deu-
terium exchange rates vary over many orders of magnitude
depending on their structural interactions: rigidly folded and
hydrogen-bonded segments of proteins exchange very slowly
(hours to years) while random coil regions can often ex-
change rapidly (milliseconds–seconds) [67]. This effect can
beused to investigate howmuch structure a disordered region
assumes upon addition of specific ligands by investigating
how the exchange rates decrease as ligand is added. A re-
cent study demonstrated the use of reverse (i.e. deuterium to
hydrogen) exchange to map peptidome-wide peptide–protein
interactions. This study highlights the fundamental possi-
bility of exploiting atomic changes to map protein interac-
tions on a global scale [68]. Using HDX technologies on
whole cells for cellular structural studies is a desirable ex-
tension of the method, however a significant hurdle is the
need to minimize back-exchange during necessary process-
ing steps such as cell lysis and protein digestion prior to
bottom-up LC-MS/MS analysis. Novel strategies in directed
evolution or metagenomics selection [69] have the potential
to identify novel types of acid-compatible specific proteases
that can help to accelerate specific digestion under conditions
that drastically slow down back-exchange. These highly acidic
conditions would be only necessary after conformational fea-
tures are “encoded” as deuterium incorporation and thus do
not affect the native structural states of cells. Ultra-rapid di-
gestion methods, mass-spectrometry compatible detergents
and faster computation of complex spectra resulting from a
large number of variable isotope changes may further help to
pave theway toward proteome-wide in vivoHDX experiments
[70, 71].
3.5 Solubility methods to probe protein
conformation
Alternativemethods based onphysical principles increasingly
complement chemical methods. One of the earliest physical
methods to characterize protein unfolding ismonitoring their
soluble fraction at a range of temperatures. Analogous to egg-
white protein in boiled eggs,most proteins irreversibly precip-
itate above their unfolding temperature. Temperatures just
slightly above the physiological growth optimum can cause
dramatic reductions of proteome solubility in cells lacking the
Hsp70 system that is an essential component of the cellular
heat shock protection system by interacting with aggregation-
prone unfolded and partially folded proteins [72,73]. The cel-
lular thermal shift assay (CETSA) assay exploits this effect
to screen ligand-dependent changes of thermal solubility of
proteins [74]. CETSA revealed drug-dependent increases of
kinase stability. Initial examples of CETSA required a large
number of samples to be screened by quantitative antibody-
based detection methods [74]. Thermal proteome profiling
(TPP) overcomes the dependence on antibodies and limited
throughput by combining the CETSA principle with TMT
10-plex mass spectrometric detection in a large temperature
window between 37 and 67C. A small number of TPP runs
in human cells and cell lysates enabled quantitatively trac-
ing drug interactions with nearly 7000 human proteins and
revealed off-target interactions of a drug [75].
Interestingly, TPP can be also applied to many transmem-
brane proteins either before or after detergent solubilisation
using a range of mild detergents [76]. A systematic compari-
son of both datasets suggests that cellular compartments al-
ter the biophysical stability ofmembraneproteins:membrane
proteins in nativemembranes aremore stable than intracellu-
lar proteins while detergent-solubilized membrane-proteins
are less stable compared to intracellular proteins. This find-
ing suggests that membrane proteins are more stable in vivo
than intracellular proteins yet significantly less stable in vitro
C© 2017 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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consistent with their reputation of being notoriously unstable
during crystallization trials in detergents. As protein struc-
tural dynamics affect protein interactions and interactions in
turn affect structural stability, characterizing these dynamics-
functional relations is of fundamental interest and has started
to be bio-medically transformative by establishing novel drug
discovery routes.
3.6 How can transient protein–protein interactions
contribute to functional diversity?
Specific protein-protein interactions (PPI) are widely consid-
ered as key to understanding cellular functions of proteins.
One might intuitively expect most PPI to be high affinity as
this ensures a high fraction of specifically bound complexes.
Highest affinity can be reached with rigid proteins, but tran-
sient and biophysically weak interactions are at the hub of
biological interaction networks [77] and ultra-affinity is rare
[78]. One of the most striking examples for two non-rigid
proteins interacting specifically is the mutually synergistic
folding of two independently flexible proteins in the ACTR-
NCBD complex [79]. Both protein domains engage in an in-
timate complex that covers a large, rather hydrophobic inter-
face to jointly regulate transcription as crucial parts of a large
number of larger proteinaceous transcription-regulatory ma-
chineries [80, 81].
3.7 High-throughput affinity-based methods to
study protein interactions
Most large-scale methods depend on short, disordered
affinity-tags [48,82]. Affinity purification (AP)-MS uses a sin-
gle affinity enrichment step and investigates all co-eluting
proteins, while tandem (T)AP-MSuses two sequential affinity
steps. More specific interactors than in sequential multiple-
affinity methods can be retrieved using two or more orthog-
onal tag systems in parallel for the same target protein, for
instance FLAG-tag and Strep-tag, in interactomes using par-
allel affinity capture (iPAC) [83] or quantitative SILAC-iPAC
[84]. Recently, GFP was introduced as novel affinity tag in
AP-MS [85], which made it possible to build on existing large
GFP-fusion libraries and to selectively enrich interactors of
most human proteins [77].
How good are thesemethods for capturing weak yet poten-
tially biologically important interactions? It is a priori not clear
how these methods might bias against the detection of very
transient binding events shorter than current affinity proto-
cols or bias toward complexes that only form in vitro in dilute
lysis and affinity purification buffers but would never form
in the crowded intracellular environment in the presence of
optimal concentrations of molecular chaperones. Clearly, or-
thogonal methods are needed to validate interactions and to
discover additional interactions that are too transient or weak
for detection by affinity-enrichment methods.
3.8 Overcoming the quantitative protein-protein
interaction validation bottle-neck
While affinity methods readily provide large lists of specific
interactors, it is generally difficult to derive predictions about
proteoform-specific dissociation constants, which would en-
able quantitative predictions for other protein concentrations.
Direct biophysical high-throughput quantification of bind-
ing strength of putative protein-protein interactions has re-
mained highly challenging. Single-molecular-interaction se-
quencing (SMI-seq) enables high-throughput quantification
of up to hundreds of protein interactions in parallel covering a
broad range of affinities by covalently crosslinking proteins to
nucleotide-barcodes for multiplexed sequencing in situ [86].
SMI-seq has been successfully applied to both water-soluble
andmembrane proteins incorporated in phospholipid bilayer
nanodiscs [86]. SMI-seq uses cell-free in vitro production
of proteins and is, therefore, not fundamentally limited by
the natural genetic code. Related approaches that offer high-
throughput and quantification of protein interactions will be
valuable for coping with the validation bottle-neck in protein-
protein interaction research.
3.9 Comparing in vitro and in vivo protein
associations
Comparison of in vitro and in vivo protein complexes is in
principle possible by fixation of protein interactions using
chemical crosslinking or using fluorescence correlation spec-
troscopy (FCS) [87]. In vivo FCS can visualize the dynamic as-
sembly and disassembly of protein complexes during the cell
cycle [87]. Crosslinking mass spectrometry (XL-MS) recently
advanced from the study of a few crosslinks of small protein
complexes to large viruses thanks to improvements on all lev-
els from MS-cleavable cross-linkers over new mass spectro-
metric strategies to novel data analysis workflows [88–90]. A
wide range of cross-linkers exist that cover zero-length to sev-
eral nanometers in distance between crosslinked molecules.
Relatively short lengths, such as 0.5 nm for MS-cleavable
DSSO, can be ideal for use in integrative biology to refine
structural models of protein complexes of partly solved com-
position [91]. Larger cross-linkers can be beneficial to eluci-
date the network of transiently or weakly binding proteins in
large protein complexes [92]. Future expansion of these novel
crosslinking-MS strategies to in vivo analysis of intracellular
protein complexes using a class of cross-linkers that com-
bines clickable affinity purification handles for enrichment
of crosslinked peptides and MS-cleavability for accelerated
peptide identification is becoming possible [93, 94].
3.10 How does protein-organelle partitioning affect
protein interactions?
Even the simplest known living cells are compart-
mentalized [95]. Membrane enrichment is crucial for
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membrane-intrinsic transporters and helps to orchestrate a
variety of metabolic pathways [96]. Eukaryotic cells have mul-
tiple membrane-enclosed organelles that enable a wide range
of physicochemical conditions to coexist in a single cell. Secre-
tory granules can have a pH of 5.0 while other compartments
typically vary between pH 6.4 and pH 7.2 [97]. Some proteins
are fully folded in one compartment but unfolded in another
[98].
3.11 Chemical proximity-labeling strategies to
discover protein co-localisation
Efficient strategies are being developed to selectively label
membrane-associated protein complexes for subsequent MS
detection. APEX2-MS [99] is based on an enzyme that cat-
alyzes the conversion of biotin phenol to a biotin radical and
rapid labeling of nearby proteins [99, 100]. Both phenol and
peroxide as co-substrates of this labeling reaction might in-
duce cellular stress in some organisms and cell types. Selec-
tive proteomic proximity labeling using tyramide (SPPLAT)
is a chemical variation to the same theme of enzymatically
creating an activated biotin-conjugate that has a short half-life
and therefore can only react in the immediate vicinity of the
activating enzyme [101,102], which is horse-radish peroxidase
in the case of SPPLAT in contrast to ascorbate peroxidase in
APEX [103].
Biotinylation is in principle also possible usingmore gentle
enzymatic approaches as biotinylation is one of the most spe-
cific known PTMs [104]. This natural specificity is, however,
a challenge for APEX-like applications that require promis-
cuous biotinylation in the proximity of the enzyme. Amutant
of the bacterial BirA ligase that lacks this substrate speci-
ficity, “BioID”, has been applied to discover transient in-
teraction partners of specific BirA-mutant labelled proteins
[105]; an accelerated unspecific biotin-ligase called BioID2
is available [106, 107]. Directed evolution might further im-
prove the activity of BioID2 at 37C as BioID2 is derived
from a highly thermophilic (Aquifex aelicus) source and dis-
plays optimal activity far above 37C [106]. Additional im-
provements of the method appear possibly for many applica-
tions if biotin-enrichment is performed on the peptide level
instead of protein level as 200-fold increased direct mass
spectrometric detectionwas demonstrated for biotin-peptides
[108].
3.12 How does lipid-less subcellular partitioning
affect protein interactions?
Even within a single organelle, biomolecules are not ho-
mogenously mixed. Active sub-organellar partitioning of-
ten involves ATP-fuelled molecular machines, for instance
dynein guiding cargo proteins along the cytoskeleton [109].
Other sub-organellar structures form spontaneously. IDPs
have been recently identified as crucial components driving
the assembly of membrane-less cellular compartments. The
prion-like domain of Xvelo, an IDP, is crucial for formation
Balbiani bodies that are a hallmark of asymmetry in oocyte
formation [110]. A variety of different flavours of protein-RNA
bodies have been identified including stress granules, nucle-
oli, Cajal bodies, and PMLbodies in the nucleus. Intriguingly,
some of their properties can be explained by sequence pat-
terns in their specific IDPs. Specific F/R/G-rich motifs in
these IDPs can efficiently drive liquid-liquid phase separa-
tions and contribute to formation of these membrane-less
bodies [111]. Thus subcellular order comes, at least in part,
out of intrinsic disorder.
Given their large molecular size, the ribosome and other
large cellular machines including the proteasome and chap-
eronins constitute nanoscopic cellular compartments in their
own right. Based on RNA-seq and isolation of translationally
halted ribosomes, and one-by-one addition of chaperones,
it is now becoming possible to selectively profile ribosomal
complexes to unravel howmolecular chaperones engage dur-
ing the translation process. This “selective ribosome profil-
ing” approach revealed that trigger factor (TF) engages in
vivo only upon emergence of 100 nascent residues in con-
trast to the earlier suggestions based on in vitro work on TF
that TF is waiting per default at the ribosomal exit tunnel
[112]; analogous approaches have great potential to trans-
form our understanding of spatiotemporal organisation of
proteostasis including synthesis and folding of membrane
proteins.
Exciting open questions related to suborganellar cellular
structures include: how is the timing of metabolic pathways
tuned by subcellular structures? Are PTMs regulating their
formation? How can we monitor systems-wide perturbations
of these structures by changing environments?
3.13 Organelle proteomics
Combining state of the art mass spectrometry, partial sep-
aration of organelles in a density gradient, and statisti-
cal analysis of resulting patterns enabled first quantitative
and nearly proteome-wide maps of cellular localizations for
eukaryotic cells, such methods include protein correlation
profiling (PCP) [113] and localization of organelle proteins by
isotope tagging (LOPIT) [18]. LOPIT has been further refined
by combination with 10-plex TMT labeling in hyper-LOPIT
[114]. TMT labeling of peptides is independent of subcel-
lular protein fractionation in density gradients and solely
used to achieve maximal subcellular resolution, coverage of
sub-cellular niches and reduction of false assignments to dif-
ferent sub-cellular niches; differential centrifugation and in-
solution digests have been used as technical variations of hy-
perLOPIT [115]. LOPIT studies have revealed thatmanymore
proteins than expected are present inmultiple locations of the
cell. This observationgives rise to intriguingquestions includ-
ing how multiple locations are linked to structural and func-
tional diversity and PTMs as well as splice variants and IDRs.
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Figure 2. Thousands of proteins have multiple alternative cel-
lular localizations [114, 118]. Mouse stem cell hyperLOPIT data
[114]. Predominant variations of the partitioning of individual
proteins into fractions of the density gradient are captured by
the first two components (denoted PC1 and PC2) of a principal
component analysis (PCA). Wnt signaling proteins APC2, CK1,
GSK3, neurodegeneration-linked Huntingtin, and the breast
cancer-linked tumor suppressor protein BRCA1 (highlighted as
solid black circles) are not assigned to a single location, charac-
teristic of proteins with mixed localization.
APC, which contains an unstructured region of some 2000
residues, for instance, can travel from the nucleus to near
the membrane and engage in several condition-dependent
transient functional protein and protein-RNA complexes in-
cluding the machinery for its own synthesis [116, 117]. It
will be a fascinating challenge to explore globally how other
IDPs act differently in different parts of the cell and how dy-
namic cellular structure form under direct control from IDP
regions. Selected examples for other Wnt pathway members
are highlighted in a HyperLOPIT plot (Fig. 2) [118].
Despite their current limitations to relatively small num-
bers of different proteins that can be observed simultane-
ously, it will be interesting to explore the complementary
benefits of cryo-electron tomography (cryo-ET) [119–121] and
super-resolution (SR) fluorescence microscopy [122]. Both
techniques are experiencing rapid technological advances and
further improvements have the potential to provide novel
insights into high-resolution spatiotemporal subcellular dy-
namics as well as fine details of tissue architectures [123].
3.14 How can tissue and organ partitioning affect
localized interactions?
Complex tissues and organs such as the human brain clearly
require a high degree of spatial organization beyond single
cells. Nearly 50 years ago, Francis Crick proposed diffusive
“morphogen” gradients as minimal ingredient for spatial or-
ganization of cells during embryogenesis [124]. Only very
recently, it has become possible to directly visualize mor-
phogen gradients in vivo using elegant organoid models that
reflect most architectural features of organs while adding
benefits of infinite expansion and culturability. Surprisingly,
the measured short-range cellular Wnt gradients are incon-
sistent with free diffusion but appear to require a cell-bound
propagation mechanism [125].
Wnt signaling as a whole is a perfect illustration of the
importance of various levels of disorder in establishingmulti-
cellular order. Many of its crucial signaling components
including the scaffolds APC, Axin and WTX contain large
IDRs up to some 2000 residues [33], have large numbers of
PTMs and alternative interactions [126], are cellularly mobile
(Fig. 2) and read the gradient signal that spans across sev-
eral cell length and ultimately established tissue and organ
shape. Curiously, the massively disordered APC protein is
also needed for proper synapse formation in the brain. Spe-
cificmutations ofAPCcorrelatewith autismand a conditional
knock-out impaired synapse maturation [127]. Defined disor-
der appears to be an architectural hallmark of some of the
most intricate structures in nature, which are just becoming
observable by mass spectrometry imaging [128].
3.15 Computational biology helping to fill the voids
in structural proteomics
Acquiring all-atom movies of the living organisms is clearly
beyond experimental reach. Computational methods increas-
ingly help to fill gaps in our understanding of structural bi-
ology. Efficient algorithms can predict secondary structure,
IDRs and increasingly 3D structure can be predicted from
readily available genomic sequences [129–131]. Despite the
astronomic conformational possibilities to arrange a given
short polypeptide sequence in 3D, de novo prediction of the
folding of100 residue long peptides based on physical prin-
ciples in silico has been shown for some examples [132].
However, the community experiment on protein structure
prediction known as CASP shows that de novo prediction
of even small, single domain proteins, while improving over
time, is still far from routine, and further shows that themost
reliable method for protein 3D structure prediction remains
the construction of protein models using the known struc-
tures of homologous proteins as templates. These template-
based models suffer from template bias, e.g. the resulting
structures are more similar to the templates than to the true
structures. Improvements in protein dynamics methods are
finally leading to approaches for reducing the degree of tem-
plate bias [133]. Similarly, themost recent force-field develop-
ments now show promise toward correct prediction of con-
formational ensemble properties of IDPs [134, 135].
Computational approaches can amplify the attainable in-
sight from highly complex multi-dimensional proteomics
C© 2017 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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Figure 3. Opening the black box of biol-
ogy. New proteomics techniques enable
a more comprehensive understanding of
the systems dynamics of life. New struc-
tural proteomics technologies can accel-
erate the analysis of the dynamics of bi-
ological regulation and extend the scope
of structural biology well beyond its de-
scriptive origins toward closer connec-
tions with cellular functions and predic-
tion of systems behaviors of proteins.
experiments by efficient dimensionality reduction methods.
PCA plots often capture most of the variation of highly di-
mensional data in visually intuitive two-dimensional plots
(Fig. 2) [136]. Significant computational science community
efforts are needed to maximize the knowledge gain from
rapidly accumulating and diversifying multi-omics datasets
to ultimately reveal fascinating new hidden ordered patterns
in complex cellular dynamic systems [137].
3.16 Outstanding challenges in proteomics
(i) Which weak or transient interactions are functionally
important?
(ii) How to quantitatively understand and predict in vivo
versus in vitro protein interactions?
(iii) How can we quantitatively link various “omics” from
DNA to RNA and the higher-order structure of proteins
including their cellular trafficking?
(iv) What are the underlying principles determining cel-
lular protein structural dynamics and how to predict
them from readily accessible genomic sequences?
(v) How can we improve the mutually enhancing ef-
forts of experimentalists and theoretical scientists to
tackle highly complex “multi-omics” projects? It is a
formidable challenge for computational biologists and
mathematicians to glean sufficient breadth of data types
from experimentalists, to discover overarching patterns
in various “omics” datasets that are fundamentally con-
nected by common cellular biology.
(vi) How can we link different protein structural states to
functional diversity? The decade-old C-value paradox
states that genome sizes are not well-correlated with
organism complexity [138]. Extensive multi-purposing
in eukaryotic proteomes might explain the excep-
tional “coding efficiency” in many eukaryotic genomes
that are too small relative to their complexity [4, 13].
Quantifying the extent of multi-purposing is highly
challenging as individual dimensions such as PTM,
C© 2017 The Authors. Proteomics Published by Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. www.proteomics-journal.com
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alternative splicing and IDR discovery, and protein
function prediction and validation are individually chal-
lenging. Expanding and integrating these efforts into
comprehensive high-throughput methods is highly de-
sirable but not yet straightforward [139].
(vii) Can we use our improved understanding of spatiotem-
poral proteome dynamics to improve life of ageing and
growing societies?
4 Conclusion
Bottom-up approaches have been very powerful in structural
biology over many decades. DNA and RNA sequencing tech-
nologies have become highly robust and widely accessible
technologies and rapid proteome-wide protein sequencing is
now possible for several organisms and transform our un-
derstanding of biology. Protein de novo folding simulations
have reached near-atomic precision for small folded domains
and IDRs.Higher-order structures are less readily predictable
so far. Complicating factors are the intracellular and envi-
ronmental fluctuations, which can be observed even in the
most simple model systems [140, 141]. Clever combinations
of traditional biochemical and physical assays with increas-
ingly rapid bottom-upmass spectrometry generatemany new
opportunities to characterize these higher-order structures
as outlined in this review (Fig. 3). Collectively, these new
bottom-up mass spectrometric techniques make it possible
to “sequence” many crucial layers of dynamic regulation of
protein structures.
Very recent breakthrough studies demonstrated the pos-
sibility of few-protein spatiotemporal engineering of organ-
isms to improve carbon fixation or accelerate the process
of switching from reduced photosynthetic activity under low-
light conditions to full photosynthetic productivity oncemore
light becomes available after clouds have passed [142, 143].
An improved proteome-wide understanding of the hidden
order in apparent disorder of higher-order protein structures
in living organisms can pave the way to de novo spatiotem-
poral engineering of organisms with beneficial properties.
While this might sound like a long way off at present, it was
well beyond the wildest imaginations just 20 years ago that
we would be able to routinely sequence entire proteomes
in an hour of measurement time [144]. It will become in-
creasingly possible to avoid late-stage failures in drug discov-
ery pipelines due to an improved understanding of cellular
dynamics.
Plenty of dynamics at the bottom of biology (Fig. 3).
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